Nutreco and BiomEdit entered into a ground-breaking, long-term strategic research and commercial partnership to bring livestock and aquaculture producers innovative and truly novel feed additives developed through microbiome technology.

Nutreco, global leader in animal nutrition and aquafeed, announces that it has taken a minority stake in animal health’s most advanced microbiome biotech company, BiomEdit. The two companies recently entered into a ground-breaking, long-term strategic research and commercial partnership – the first since BiomEdit was founded – to bring livestock and aquaculture producers innovative and truly novel feed additives developed through microbiome technology. The recent announcement represents a further strengthening of this partnership.

“Through this investment, we are reinforcing the unique collaboration that brings together BiomEdit’s state-of-the-art microbiome discovery platform and Nutreco’s customer access and distribution capabilities,” said Fulco van Lede, CEO Nutreco. “We’re excited about its potential to help us super-charge our supply of proprietary ultra-specialty ingredients, speed up progress on our purpose of Feeding the Future and create a more sustainable future for our industry.”

“Nutreco's investment in BiomEdit underscores our strategic partnership and a shared mission to create novel animal health solutions through the untapped potential of the microbiome,” said Aaron Schacht, CEO of BiomEdit. “We are pleased that Nutreco, a global leader in animal nutrition and aquafeed, is joining our roster of world-class Series A investors to help fuel innovation in feed additive products."